For the study, researchers analyzed treatment data and death records for 48,274 adults admitted to outpatient treatment centers for opioid use disorder in Maryland from 2015-16.
A total of 371 opioid overdose deaths occurred during the study period. Researchers found patients treated with anti-opioid drugs such as methadone or buprenorphine were 82 percent less likely to die of an overdose than those receiving non-medication treatments such as psychotherapy.
However, patients were at an equally high risk of overdose after leaving their treatment programs, regardless of which type of therapy they received.
More articles on opioids:
Ohio county considers adding 2nd morgue for surge in opioid overdose deaths
Medicaid expansion linked to drop in opioid overdose deaths
How Houston Methodist reduced opioid prescriptions by nearly 77%
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
